Recent News

• 10.26.2026 - Onco360® Has Been Selected as a National Pharmacy Partner for ZEGFROVY® (sunvozertinib)
• 10.21.2026 - StepStone Youth & Family Services Advocating for Youth in Foster Care
• 10.06.2026 - Onco360® Has Been Selected as a National Specialty Pharmacy Partner for BEQALZI™ (sonrotoclax)
• 09.21.2026 - Onco360® is a participating specialty pharmacy in the ZENBEXUS™ (iberdomide) limited dispense network
• 09.17.2026 - Onco360® Has Been Selected as a National Pharmacy Partner for ETCAMAH™ (camizestrant)
• 09.09.2026 - Onco360® Has Been Selected as Part of an Ultra-Narrow Specialty Pharmacy Network for MIMRYLO™ (rusfertide)
• 09.08.2026 - CareMed Has Been Selected as a National Pharmacy Partner by BioCryst and Adds Orladeyo® (berotralstat) to Growing Rare Disease Portfolio
• 08.27.2026 - Onco360® Has Been Selected as a National Pharmacy Partner for RASONQUE™ (daraxonrasib)
• 08.12.2026 - Quality, Innovation, and High-Value Care at Home
• 07.29.2026 - Onco360® Has Been Selected as a National Pharmacy Partner for VEPPANU™ (vepdegestrant)

Recent Filings

• 09.16.2026 - 4 Statement of changes in beneficial ownership of securities
• 09.14.2026 - 144 Report of proposed sale of securities
• 08.06.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 07.31.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 07.31.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 07.31.2026 - EX-99.1 EX-99.1
• 07.31.2026 - 8-K Current report
• 07.28.2026 - 4 Statement of changes in beneficial ownership of securities
• 07.27.2026 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 06.22.2026 - 4 Statement of changes in beneficial ownership of securities